Terms: = Testicular cancer AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Prognosis
7 results:
1. p53 and mdm2 expression in primary and metastatic testicular germ cell tumors: Association with clinical outcome.
Lobo J; Alzamora MA; Guimarães R; Cantante M; Lopes P; Braga I; Maurício J; Jerónimo C; Henrique R
Andrology; 2020 Sep; 8(5):1233-1242. PubMed ID: 32384200
[TBL] [Abstract] [Full Text] [Related]
2. [Intimal sarcoma of pulmonary arteries].
Sejben A; Tiszlavicz L; Furák J; Boros K; Sápi Z; Zombori T
Orv Hetil; 2020 Feb; 161(6):232-236. PubMed ID: 32008347
[TBL] [Abstract] [Full Text] [Related]
3. testicular germ cell tumor genomics.
Woldu SL; Amatruda JF; Bagrodia A
Curr Opin Urol; 2017 Jan; 27(1):41-47. PubMed ID: 27584029
[TBL] [Abstract] [Full Text] [Related]
4. Biological markers of cisplatin resistance in advanced testicular germ cell tumours.
García-Velasco A; Durán I; García E; Tarón M; Ballestín C; Castellanos D; Cortés-Funés H; Paz-Ares L
Clin Transl Oncol; 2012 Jun; 14(6):452-7. PubMed ID: 22634534
[TBL] [Abstract] [Full Text] [Related]
5. Therapeutic potential of mdm2 inhibition in malignant germ cell tumours.
Bauer S; Mühlenberg T; Leahy M; Hoiczyk M; Gauler T; Schuler M; Looijenga L
Eur Urol; 2010 Apr; 57(4):679-87. PubMed ID: 19560254
[TBL] [Abstract] [Full Text] [Related]
6. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
[TBL] [Abstract] [Full Text] [Related]
7. The p53 and mdm-2 genes in human testicular germ-cell tumors.
Riou G; Barrois M; Prost S; Terrier MJ; Theodore C; Levine AJ
Mol Carcinog; 1995 Mar; 12(3):124-31. PubMed ID: 7893365
[TBL] [Abstract] [Full Text] [Related]
